- Home
- POOL vs WGSWW Comparison
POOL vs WGSWW Comparison
Compare POOL & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- WGSWW
- Stock Information
- Founded
- POOL 1993
- WGSWW 2017
- Country
- POOL United States
- WGSWW United States
- Employees
- POOL N/A
- WGSWW 1000
- Industry
- POOL Industrial Specialties
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- POOL Consumer Discretionary
- WGSWW Technology
- Exchange
- POOL Nasdaq
- WGSWW Nasdaq
- Market Cap
- POOL N/A
- WGSWW N/A
- IPO Year
- POOL 1995
- WGSWW N/A
- Fundamental
- Price
- POOL $291.59
- WGSWW $0.14
- Analyst Decision
- POOL Hold
- WGSWW
- Analyst Count
- POOL 9
- WGSWW 0
- Target Price
- POOL $348.33
- WGSWW N/A
- AVG Volume (30 Days)
- POOL 562.5K
- WGSWW 36.6K
- Earning Date
- POOL 04-24-2025
- WGSWW 02-18-2025
- Dividend Yield
- POOL 1.65%
- WGSWW N/A
- EPS Growth
- POOL N/A
- WGSWW N/A
- EPS
- POOL 10.70
- WGSWW N/A
- Revenue
- POOL $5,261,669,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- POOL $2.96
- WGSWW N/A
- Revenue Next Year
- POOL $4.88
- WGSWW N/A
- P/E Ratio
- POOL $27.24
- WGSWW N/A
- Revenue Growth
- POOL N/A
- WGSWW 50.79
- 52 Week Low
- POOL $284.27
- WGSWW $0.17
- 52 Week High
- POOL $395.60
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- POOL 39.22
- WGSWW N/A
- Support Level
- POOL $293.11
- WGSWW N/A
- Resistance Level
- POOL $318.40
- WGSWW N/A
- Average True Range (ATR)
- POOL 14.70
- WGSWW 0.00
- MACD
- POOL -0.59
- WGSWW 0.00
- Stochastic Oscillator
- POOL 21.45
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.